Journal of Vascular Surgery
Volume 47, Issue 3 , Pages 566-570 , March 2008

Genetic variation in heme oxygenase 1 (HMOX1) and the risk of recurrent venous thromboembolism

  • Stefan Mustafa, MD, PhD

      Affiliations

    • Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria
  • ,
  • Ansgar Weltermann, MD

      Affiliations

    • Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
  • ,
  • Robert Fritsche, MD, ScM

      Affiliations

    • Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria
    • Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • ,
  • Claudia Marsik, MD

      Affiliations

    • Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria
    • Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • ,
  • Oswald Wagner, MD

      Affiliations

    • Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria
  • ,
  • Paul A. Kyrle, MD

      Affiliations

    • Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
  • ,
  • Sabine Eichinger, MD

      Affiliations

    • Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationCorrespondence: Sabine Eichinger, Department of Internal Medicine I, Waehringer Guertel 18-20, 1090 Vienna, Austria.

Received 18 April 2007 ,Accepted 26 September 2007.

  • Image Result

    GT-repeat alleles in patients with and without recurrent venous thromboembolism. Frequency of GT-repeat alleles in patients with recurrent (black columns) and without recurrent VTE (grey columns).

    GT-repeat alleles in patients with and without recurrent venous thromboembolism. Frequency of GT-repeat alleles in patients with recurrent (black columns) and without recurrent VTE (grey columns).

  • Image Result

    Kaplan Meier estimates of the risk of recurrent venous thromboembolism for heterozygous carriers of an L-allele compared with non-carriers.

    Kaplan Meier estimates of the risk of recurrent venous thromboembolism for heterozygous carriers of an L-allele compared with non-carriers.

 Competition of interest: none.

PII: S0741-5214(07)01549-2

doi: 10.1016/j.jvs.2007.09.060

Journal of Vascular Surgery
Volume 47, Issue 3 , Pages 566-570 , March 2008